Literature DB >> 16730091

A novel flow based hollow-fiber blood-brain barrier in vitro model with immortalised cell line PBMEC/C1-2.

Winfried Neuhaus1, Regina Lauer, Silvester Oelzant, Urs P Fringeli, Gerhard F Ecker, Christian R Noe.   

Abstract

A flow based hollow-fiber in vitro model of the blood-brain barrier (BBB) was established. The immortalised porcine brain microvascular endothelial cell line PBMEC/C1-2 was cultured in a pulsatile hollow-fiber cartridge system (Cellmax Quad). The usability of PBMEC/C1-2 in the flow based hollow-fiber model was increased from three days in the originally used Transwell model up to four months due to the application of shear stress and co-culturing with glioma cell line C6. It was shown that the tightness of PBMEC/C1-2 layers was enhanced significantly in astrocyte conditioned medium (ACM) and in co-culture. The morphology of PBMEC/C1-2 and C6 was visualised by environmental scanning electron microscopy (ESEM). Permeation studies were accomplished with a set of benzodiazepines. The raw data were processed with three different calculation models and the results were compared with permeability coefficients obtained with an established Transwell model. In summary a flow based hollow-fiber BBB in vitro model was developed, which can be used to perform experiments with physiological (e.g., regulation of BBB permeability), pharmacological (e.g., pharmacokinetics and dynamics) and pathophysiological (e.g., effects of diseases on BBB permeability and vice versa) objectives.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16730091     DOI: 10.1016/j.jbiotec.2006.02.019

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  21 in total

Review 1.  3D in vitro modeling of the central nervous system.

Authors:  Amy M Hopkins; Elise DeSimone; Karolina Chwalek; David L Kaplan
Journal:  Prog Neurobiol       Date:  2014-11-22       Impact factor: 11.685

Review 2.  On the genealogy of tissue engineering and regenerative medicine.

Authors:  Himanshu Kaul; Yiannis Ventikos
Journal:  Tissue Eng Part B Rev       Date:  2014-12-23       Impact factor: 6.389

Review 3.  TEER measurement techniques for in vitro barrier model systems.

Authors:  Balaji Srinivasan; Aditya Reddy Kolli; Mandy Brigitte Esch; Hasan Erbil Abaci; Michael L Shuler; James J Hickman
Journal:  J Lab Autom       Date:  2015-01-13

4.  Improved Method for the Establishment of an In Vitro Blood-Brain Barrier Model Based on Porcine Brain Endothelial Cells.

Authors:  Simone S E Nielsen; Piotr Siupka; Ana Georgian; Jane E Preston; Andrea E Tóth; Siti R Yusof; N Joan Abbott; Morten S Nielsen
Journal:  J Vis Exp       Date:  2017-09-24       Impact factor: 1.355

5.  In Vitro Models of the Blood-Brain Barrier.

Authors:  Winfried Neuhaus
Journal:  Handb Exp Pharmacol       Date:  2021

Review 6.  Human Blood-Brain-Barrier In Vitro Models: Overview and Applications.

Authors:  Zameel Cader
Journal:  Handb Exp Pharmacol       Date:  2022

Review 7.  In vitro cerebrovascular modeling in the 21st century: current and prospective technologies.

Authors:  Christopher A Palmiotti; Shikha Prasad; Pooja Naik; Kaisar M D Abul; Ravi K Sajja; Anilkumar H Achyuta; Luca Cucullo
Journal:  Pharm Res       Date:  2014-08-07       Impact factor: 4.200

8.  Endothelial cell capture of heparin-binding growth factors under flow.

Authors:  Bing Zhao; Changjiang Zhang; Kimberly Forsten-Williams; Jun Zhang; Michael Fannon
Journal:  PLoS Comput Biol       Date:  2010-10-28       Impact factor: 4.475

9.  Isolation of Cerebral Capillaries from Fresh Human Brain Tissue.

Authors:  Anika M S Hartz; Julia A Schulz; Brent S Sokola; Stephanie E Edelmann; Andrew N Shen; Ralf G Rempe; Yu Zhong; Nader El Seblani; Bjoern Bauer
Journal:  J Vis Exp       Date:  2018-09-12       Impact factor: 1.355

10.  Identification of peptide ligands for targeting to the blood-brain barrier.

Authors:  Inge van Rooy; Serpil Cakir-Tascioglu; Pierre-Olivier Couraud; Ignacio A Romero; Babette Weksler; Gert Storm; Wim E Hennink; Raymond M Schiffelers; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2010-02-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.